Baxter International Inc (BAX)

$17.89 +0.36 (2.05%)
Market Cap 9.05B
Revenue (ttm) 11.24B
Net Income (ttm) -957.00M
EPS (ttm) N/A
PE Ratio 8.65
Forward PE 9.38
Profit Margin -8.51%
Debt to Equity Ratio 1.57
Volume 7,160,700
Avg Vol 8,583,274
Day's Range N/A - N/A
Shares Out 516.47M
Stochastic %K 90%
Beta 0.62
Analysts Sell
Price Target $20.55

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed system...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 224 948 2000
Address:
One Baxter Parkway, Deerfield, United States
CapitalMonk
CapitalMonk May. 13 at 2:56 AM
$BAX Price: $17.89 (+2.05%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.57% RSI: 46.6 | Momentum: Moderate Volume: -37.2% vs avg Volatility: 2.66% Support: $16.17 | Resistance: $19.19 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
g_man_
g_man_ May. 11 at 11:52 PM
$BAX time to tip my toe in
0 · Reply
ssdsddssd2
ssdsddssd2 May. 11 at 4:39 PM
$BAX add more - 50+ in 2027
0 · Reply
MarketBeat
MarketBeat May. 10 at 1:06 AM
https://marketbeat.com/a/8644597/ $BAX Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting
0 · Reply
Bushpig
Bushpig May. 8 at 4:01 PM
$BAX POS going to zero, worst $1000.00 investment ever.
1 · Reply
Bushpig
Bushpig May. 8 at 4:01 PM
$BAX POS going to zero, worst $1000.00 investment ever
1 · Reply
Bushpig
Bushpig May. 8 at 3:35 PM
$BAX POS going to zero, worst $1000.00 investment ever!
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Windee
Windee May. 5 at 2:17 PM
$BAX Down over 80% year to date. Looks like they’ll never recover. CAN’T FLOG A DEAD HORSE! Market share seems to have gone to $BDX $MRK $PFE & $ABT
1 · Reply
UmmHmmDaddy
UmmHmmDaddy May. 4 at 8:37 PM
$BAX premium trash
0 · Reply
Latest News on BAX
Baxter International Transcript: AGM 2026

May 5, 2026, 10:00 AM EDT - 7 days ago

Baxter International Transcript: AGM 2026

Baxter price target raised to $27 from $25 at Barclays

2026-05-04T09:15:09.000Z - 9 days ago

Baxter price target raised to $27 from $25 at Barclays

Baxter price target lowered to $17 from $19 at Goldman Sachs

2026-05-01T13:39:22.000Z - 11 days ago

Baxter price target lowered to $17 from $19 at Goldman Sachs

Baxter International Earnings Call Transcript: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 12 days ago

Baxter International Earnings Call Transcript: Q1 2026

Baxter beats quarterly expectations on strong demand for medical devices

Apr 30, 2026, 8:26 AM EDT - 13 days ago

Baxter beats quarterly expectations on strong demand for medical devices

Baxter Reports First-Quarter 2026 Results

Apr 30, 2026, 7:15 AM EDT - 13 days ago

Baxter Reports First-Quarter 2026 Results

Baxter showcases Global Surgical Solutions portfolio at AORN Conference

2026-04-13T13:15:57.000Z - 4 weeks ago

Baxter showcases Global Surgical Solutions portfolio at AORN Conference

Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

Apr 13, 2026, 9:00 AM EDT - 4 weeks ago

Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

Apr 8, 2026, 4:15 PM EDT - 4 weeks ago

Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

Baxter price target lowered to $22 from $23 at Evercore ISI

2026-04-06T12:26:05.000Z - 5 weeks ago

Baxter price target lowered to $22 from $23 at Evercore ISI

These 20 stocks in the S&P 500 fell hardest during March

Mar 31, 2026, 10:33 AM EDT - 6 weeks ago

These 20 stocks in the S&P 500 fell hardest during March

AMCR AXON BLDR CCL CNC DG EL

Baxter introduces IV Verify Line Labeling System

2026-03-30T12:52:31.000Z - 6 weeks ago

Baxter introduces IV Verify Line Labeling System

Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

Mar 30, 2026, 8:30 AM EDT - 6 weeks ago

Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Mar 25, 2026, 4:30 PM EDT - 6 weeks ago

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot

Mar 25, 2026, 9:00 AM EDT - 6 weeks ago

Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot

EU regulator warns of shortage in Baxter's cancer treatment until early 2027

Mar 24, 2026, 9:48 AM EDT - 7 weeks ago

EU regulator warns of shortage in Baxter's cancer treatment until early 2027

Baxter CFO Joel Grade to depart

2026-03-16T13:02:30.000Z - 2 months ago

Baxter CFO Joel Grade to depart

Baxter backs FY26 adjusted EPS view $1.85-$2.05, consensus $1.92

2026-03-16T13:01:53.000Z - 2 months ago

Baxter backs FY26 adjusted EPS view $1.85-$2.05, consensus $1.92

Baxter Announces CFO Transition

Mar 16, 2026, 8:45 AM EDT - 2 months ago

Baxter Announces CFO Transition

Baxter International Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 1:00 PM EDT - 2 months ago

Baxter International Transcript: Barclays 28th Annual Global Healthcare Conference

Baxter price target lowered to $19 from $21 at Citi

2026-03-11T09:27:21.000Z - 2 months ago

Baxter price target lowered to $19 from $21 at Citi

Baxter International Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

Feb 26, 2026, 12:15 PM EST - 2 months ago

Baxter International Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

Baxter price target lowered to $17 from $21 at Goldman Sachs

2026-02-17T15:05:56.000Z - 3 months ago

Baxter price target lowered to $17 from $21 at Goldman Sachs

Baxter price target lowered to $19 from $21 at UBS

2026-02-16T12:55:46.000Z - 3 months ago

Baxter price target lowered to $19 from $21 at UBS

Baxter price target lowered to $20 from $22 at Deutsche Bank

2026-02-13T13:41:06.000Z - 3 months ago

Baxter price target lowered to $20 from $22 at Deutsche Bank

Baxter price target lowered to $25 from $30 at Barclays

2026-02-13T11:47:52.000Z - 3 months ago

Baxter price target lowered to $25 from $30 at Barclays

Baxter price target lowered to $19 from $21 at Jefferies

2026-02-12T20:55:16.000Z - 3 months ago

Baxter price target lowered to $19 from $21 at Jefferies

Baxter price target lowered to $20 from $22 at Stifel

2026-02-12T20:45:37.000Z - 3 months ago

Baxter price target lowered to $20 from $22 at Stifel

Baxter International Earnings Call Transcript: Q4 2025

Feb 12, 2026, 8:30 AM EST - 3 months ago

Baxter International Earnings Call Transcript: Q4 2025

Baxter forecast 2026 profit below estimates

Feb 12, 2026, 7:24 AM EST - 3 months ago

Baxter forecast 2026 profit below estimates

Baxter Reports Fourth-Quarter 2025 Results

Feb 12, 2026, 7:15 AM EST - 3 months ago

Baxter Reports Fourth-Quarter 2025 Results

Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

Jan 21, 2026, 5:00 PM EST - 3 months ago

Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Jan 13, 2026, 9:00 AM EST - 4 months ago

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Baxter International Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 4 months ago

Baxter International Transcript: 44th Annual J.P. Morgan Healthcare Conference

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Jan 8, 2026, 9:00 AM EST - 4 months ago

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Jan 6, 2026, 5:14 PM EST - 4 months ago

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference

Dec 12, 2025, 10:32 AM EST - 5 months ago

DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

Dec 11, 2025, 8:30 AM EST - 5 months ago

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 4, 2025, 4:15 PM EST - 5 months ago

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 4, 2025, 7:51 AM EST - 5 months ago

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter International Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 10:50 AM EST - 5 months ago

Baxter International Transcript: Evercore ISI 8th Annual HealthCONx Conference

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Nov 19, 2025, 4:15 PM EST - 6 months ago

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Baxter Announces Tender Offers for 2026 Notes and 2027 Notes

Nov 19, 2025, 8:54 AM EST - 6 months ago

Baxter Announces Tender Offers for 2026 Notes and 2027 Notes

Baxter International Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 8:00 AM EST - 6 months ago

Baxter International Transcript: Jefferies London Healthcare Conference 2025

Baxter Declares Quarterly Dividend

Nov 11, 2025, 4:30 PM EST - 6 months ago

Baxter Declares Quarterly Dividend

BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline

Nov 10, 2025, 8:15 AM EST - 6 months ago

BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

Nov 7, 2025, 8:45 AM EST - 6 months ago

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

Baxter International Earnings Call Transcript: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 6 months ago

Baxter International Earnings Call Transcript: Q3 2025

Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact

Oct 30, 2025, 8:27 AM EDT - 6 months ago

Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact

Baxter Reports Third-Quarter 2025 Results

Oct 30, 2025, 7:15 AM EDT - 6 months ago

Baxter Reports Third-Quarter 2025 Results

CapitalMonk
CapitalMonk May. 13 at 2:56 AM
$BAX Price: $17.89 (+2.05%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.57% RSI: 46.6 | Momentum: Moderate Volume: -37.2% vs avg Volatility: 2.66% Support: $16.17 | Resistance: $19.19 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
g_man_
g_man_ May. 11 at 11:52 PM
$BAX time to tip my toe in
0 · Reply
ssdsddssd2
ssdsddssd2 May. 11 at 4:39 PM
$BAX add more - 50+ in 2027
0 · Reply
MarketBeat
MarketBeat May. 10 at 1:06 AM
https://marketbeat.com/a/8644597/ $BAX Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting
0 · Reply
Bushpig
Bushpig May. 8 at 4:01 PM
$BAX POS going to zero, worst $1000.00 investment ever.
1 · Reply
Bushpig
Bushpig May. 8 at 4:01 PM
$BAX POS going to zero, worst $1000.00 investment ever
1 · Reply
Bushpig
Bushpig May. 8 at 3:35 PM
$BAX POS going to zero, worst $1000.00 investment ever!
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Windee
Windee May. 5 at 2:17 PM
$BAX Down over 80% year to date. Looks like they’ll never recover. CAN’T FLOG A DEAD HORSE! Market share seems to have gone to $BDX $MRK $PFE & $ABT
1 · Reply
UmmHmmDaddy
UmmHmmDaddy May. 4 at 8:37 PM
$BAX premium trash
0 · Reply
Windee
Windee May. 1 at 6:26 PM
$BAX Bought the dip. Let’s see how far she goes. What do you think? Maybe a turnaround?
0 · Reply
FLTR8R
FLTR8R Apr. 30 at 2:18 PM
$BAX BANG!!!
0 · Reply
iNvEsTiNgiSEZ
iNvEsTiNgiSEZ Apr. 30 at 2:02 PM
$BAX short every pop free money
2 · Reply
FLTR8R
FLTR8R Apr. 30 at 1:37 PM
$BAX Buying with bith hands!!! Let's go!!!
0 · Reply
FLTR8R
FLTR8R Apr. 30 at 11:34 AM
$BAX Bitch about to get re rated!!! LFG!!!
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 30 at 11:23 AM
$BAX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 down -112.00% YoY • Reported revenue of $2.7B up 2.90% YoY • Baxter reiterated its full-year 2026 financial outlook, expecting reported sales growth from continuing operations to be flat to 1% and adjusted diluted EPS from $1.85 to $2.05.
0 · Reply
iNvEsTiNgiSEZ
iNvEsTiNgiSEZ Apr. 29 at 7:58 PM
$BAX haha so predictable this POS going to $10 .. every pop short this turd. Needs to be ripped apart and taken private at $5 . Joke products. Joke company.
2 · Reply
Quantumup
Quantumup Apr. 29 at 10:26 AM
Citizens⬆️ $AXGN's PT to $50 from $42 and reiterated at Market Outperform. $BAX $SYK IART MDGX Mizuho⬆️PT to $55 from $40 and reiterated at Outperform. Here's what Citizens and Mizuho had to say: https://x.com/Quantumup1/status/2049434277276758434?s=20
0 · Reply
Breakerofchains
Breakerofchains Apr. 27 at 2:35 PM
$BAX they are setting themselves up nicely for a beat on earnings only expecting .31 pennies!!!!! Staying the course with a 3/4 position
0 · Reply
dolar4676
dolar4676 Apr. 23 at 1:01 PM
$BAX to 25$ soon
0 · Reply
TryAndShareTheWealth
TryAndShareTheWealth Apr. 21 at 10:16 AM
$BAX high short opportunity here. Mark my words. Don’t let the cat outta the bag
1 · Reply
Following_the_trend
Following_the_trend Apr. 17 at 3:15 PM
$BAX Above the 50 day finally. On watch.
0 · Reply